Create account Log in

Precision diagnostics in the clinic

Access our integrated multiomic blood and tissue profiling solutions. BostonGene's AI-driven pipeline translates actionable findings into personalized treatment recommendations and identifies available clinical trials.

Identifying the most effective treatment options for every cancer patient through our comprehensive clinical tests and services portfolio

BostonGene Tumor Portrait™ test

The Tumor Portrait™ test identifies key biomarkers for response to various therapies in patients with advanced solid tumors.

BostonGene Liquid Biopsy test

Plasma-based genomic profiling for solid cancers detects critical, clinically actionable biomarkers.

Immunohistochemistry (IHC) test

Testing for clinically actionable biomarkers such as PD-L1 & MMR.

Unknown Primary test

Identifies the tumor’s origin using DNA and RNA sequencing.

Immune system profiling

Snapshot of the patient’s immune health by identification of hundreds of different cell types from a single tube of blood.

Helpful resources

Tumor Portrait™ test overview Tumor microenvironment types NGS performance metrics - FFPE TRF explanation Test requisition form About BostonGene